Local Inhibition of Liver Fibrosis by Specific Delivery of a Platelet-Derived Growth Factor Kinase Inhibitor to Hepatic Stellate Cells
Teresa Gonzalo(University of Groningen), Robbert J. Kok(Utrecht University), M. van de Bovenkamp, Anne-Miek van Loenen(Dialyse Centrum Groningen), Catharina Reker‐Smit, M. Lacombe(Université du Québec à Rimouski), Klaas Poelstra(University of Groningen), László Őrfi, Leonie Beljaars(University of Groningen), Dirk K. F. Meijer(University of Groningen), Frank Opdam(Alltech (United States)), Gÿorgý Kéri(Semmelweis University), Kai Temming(University of Groningen)
Cited by 78
Related Papers
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396
Diverse origins of the myofibroblast—implications for kidney fibrosis
|Nature Reviews Nephrology|2015|305
Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges
|International Journal of Pharmaceutics|2016|285